News, Analysis & Insights on Nutrition, Supplements, and Health
Several high-profile lawsuits challenging the legal status of CBD products have been stayed (effectively put on ice until the FDA outlines a regulatory path forward for CBD in foods & supplements) or voluntarily dismissed in recent weeks.
A new wave of products were recently introduced and this month cast a spotlight on the growing demand for immunity health.
The manufacturer says its new product, dubbed CSAT+, a blend of carob bean extracts, is showing promise in weight management and metabolic syndrome (MetS).
The National Advertising Division has ruled that GSK must stop calling some of its Benefiber prebiotic supplements ‘100% natural.’ It’s a ruling that could be viewed as troublesome for other prebiotic ingredients.
A newly identified “metabolic signature” can evaluate an individual’s adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research.
Eye health may be the next big opportunity for nootropics products that are more traditionally known for their cognitive and energy benefits.